Retrospective 57 patient Phase I/II study comparing AIQ technology to experienced reader for evaluating heterogeneous system amyloid build up in multiple organs.
“This approach will significantly impact the ease of use and improve accuracy of image interpretation that will ultimately benefit clinical management of patients with amyloidosis.”
- Weisman et al., WMIC 2021
Retrospective study of 58 melanoma patients treated with ICI therapy evaluated in a partnership with University of Wisconsin Carbone Cancer Center.
Accurate quantification of changes in the lung could significantly predict which patients had pneumonitis prior to actual diagnosis with an AUC of 0.99.
13 prostate cancer patients from a Phase I/II trial treated with 177 Lu-PSMA-617 and imaged pre- and post-treatment with 68Ga-PSMA11-PET.
Quantification of PSMA expression shows
1. Associations between PSMA PET SUV and response by both overall survival and PSA response
2. Associations between degree of PSMA PET SUV in PSMA-expressing non-tumor tissues and adverse events
Nauseef et al., American Society of American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU) 2022.
Intended for research use only. Not intended for use in treatment of patients.